Open Access
- 14 November 2019
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 20 (22) , 5722
Abstract
Inherited retinal dystrophies (IRDs) are a group of clinically and genetically heterogeneous degenerative disorders. To date, mutations have been associated with IRDs in over 270 disease genes, but molecular diagnosis still remains elusive in about a third of cases. The methodologic developments in genome sequencing techniques that we have witnessed in this last decade have represented a turning point not only in diagnosis and prognosis but, above all, in the identification of new therapeutic perspectives. The discovery of new disease genes and pathogenetic mechanisms underlying IRDs has laid the groundwork for gene therapy approaches. Several clinical trials are ongoing, and the recent approval of Luxturna, the first gene therapy product for Leber congenital amaurosis, marks the beginning of a new era. Due to its anatomical and functional characteristics, the retina is the organ of choice for gene therapy, although there are quite a few difficulties in the translational approaches from preclinical models to humans. In the first part of this review, an overview of the current knowledge on methodological issues and future perspectives of gene therapy applied to IRDs is discussed; in the second part, the state of the art of clinical trials on the gene therapy approach in IRDs is illustrated.Keywords
This publication has 184 references indexed in Scilit:
- Reading Frame Correction by Targeted Genome Editing Restores Dystrophin Expression in Cells From Duchenne Muscular Dystrophy PatientsMolecular Therapy, 2013
- AAV-Mediated Gene Therapy for Choroideremia: Preclinical Studies in Personalized ModelsPLOS ONE, 2013
- One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome EngineeringCell, 2013
- X-linked juvenile retinoschisis: Clinical diagnosis, genetic analysis, and molecular mechanismsProgress in Retinal and Eye Research, 2012
- Suppression of rds Expression by siRNA and Gene Replacement Strategies for Gene Therapy Using rAAV Vector2011
- Effect of Gene Therapy on Visual Function in Leber's Congenital AmaurosisNew England Journal of Medicine, 2008
- Correction of the disease phenotype in the mouse model of Stargardt disease by lentiviral gene therapyGene Therapy, 2008
- Reversal of Blindness in Animal Models of Leber Congenital Amaurosis Using Optimized AAV2-mediated Gene TransferMolecular Therapy, 2008
- Preservation of photoreceptor morphology and function in P23H rats using an allele independent ribozymeExperimental Eye Research, 2007
- Toward a Gene Therapy for Dominant Disease: Validation of an RNA Interference-Based Mutation-Independent ApproachMolecular Therapy, 2005